8086 — Nipro Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapNeutral

Annual income statement for Nipro, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	455,559	494,789	545,199	586,785	644,586
Cost of Revenue
Gross Profit	138,841	149,270	163,450	171,320	190,884
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	438,518	475,714	530,539	570,736	618,176
Operating Profit	17,041	19,075	14,660	16,049	26,410
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	17,519	23,243	16,777	19,219	19,087
Provision for Income Taxes
Net Income After Taxes	15,038	15,066	5,934	12,170	6,670
Minority Interest
Net Income Before Extraordinary Items
Net Income	14,210	13,455	4,575	11,110	5,115
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	14,209	13,455	4,574	11,109	5,113
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	159	110	40.1	89.5	44.6
Dividends per Share